Your browser doesn't support javascript.
loading
Identification of Rigosertib for the Treatment of Recessive Dystrophic Epidermolysis Bullosa-Associated Squamous Cell Carcinoma.
Atanasova, Velina S; Pourreyron, Celine; Farshchian, Mehdi; Lawler, Michael; Brown, Christian A; Watt, Stephen A; Wright, Sheila; Warkala, Michael; Guttmann-Gruber, Christina; Hofbauer, Josefina Piñón; Fuentes, Ignacia; Prisco, Marco; Rashidghamat, Elham; Has, Cristina; Salas-Alanis, Julio C; Palisson, Francis; Hovnanian, Alain; McGrath, John A; Mellerio, Jemima E; Bauer, Johann W; South, Andrew P.
Afiliación
  • Atanasova VS; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Pourreyron C; Division of Cellular Medicine, University of Dundee, Dundee, United Kingdom.
  • Farshchian M; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Lawler M; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Brown CA; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Watt SA; Division of Cellular Medicine, University of Dundee, Dundee, United Kingdom.
  • Wright S; Division of Cellular Medicine, University of Dundee, Dundee, United Kingdom.
  • Warkala M; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Guttmann-Gruber C; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Hofbauer JP; EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Austria.
  • Fuentes I; Fundación DEBRA Chile, Santiago, Chile.
  • Prisco M; Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Rashidghamat E; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Has C; St. John's Institute of Dermatology, King's College London (Guy's Campus), London, United Kingdom.
  • Salas-Alanis JC; Department of Dermatology, Medical Center-University of Freiburg, Faculty of Medicine, Freiburg, Germany.
  • Palisson F; Instituto Dearmatologico de Jalisco, Guadalajara, Mexico.
  • Hovnanian A; Fundación DEBRA Chile, Santiago, Chile.
  • McGrath JA; Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.
  • Mellerio JE; INSERM UMR 1163, Paris, France.
  • Bauer JW; Imagine Institute, Paris, France.
  • South AP; St. John's Institute of Dermatology, King's College London (Guy's Campus), London, United Kingdom.
Clin Cancer Res ; 25(11): 3384-3391, 2019 06 01.
Article en En | MEDLINE | ID: mdl-30846478
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Sulfonas / Carcinoma de Células Escamosas / Epidermólisis Ampollosa Distrófica / Glicina / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Sulfonas / Carcinoma de Células Escamosas / Epidermólisis Ampollosa Distrófica / Glicina / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article